LLY
1,027.44
+2.13%↑
JNJ
211.44
+0.72%↑
ABBV
223.45
-0.16%↓
UNH
341.39
+1.44%↑
AZN
89.79
-0.45%↓
LLY
1,027.44
+2.13%↑
JNJ
211.44
+0.72%↑
ABBV
223.45
-0.16%↓
UNH
341.39
+1.44%↑
AZN
89.79
-0.45%↓
LLY
1,027.44
+2.13%↑
JNJ
211.44
+0.72%↑
ABBV
223.45
-0.16%↓
UNH
341.39
+1.44%↑
AZN
89.79
-0.45%↓
LLY
1,027.44
+2.13%↑
JNJ
211.44
+0.72%↑
ABBV
223.45
-0.16%↓
UNH
341.39
+1.44%↑
AZN
89.79
-0.45%↓
LLY
1,027.44
+2.13%↑
JNJ
211.44
+0.72%↑
ABBV
223.45
-0.16%↓
UNH
341.39
+1.44%↑
AZN
89.79
-0.45%↓
24h
Current
Min
17.83
Max
18.11
Recommendations | Buy |
|---|---|
12 Months Forecast | +93.69% upside |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
19 gru 2024, 00:26 UTC
Mesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- Update
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 35 USD 93.69%
High 35 USD
Low 35 USD
Based on 1 Wall Street analysts offering 12 month price targets forMesoblast Ltd ADR - Dist in the last 3 months.
By TipRanks
Buy
1 ratings
1
Buy
0
Hold
0
Sell
Based on 1 analysts giving stock ratings to Mesoblast Ltd ADR - Dist in the past 3 months.
$